Clinical Trials Directory

Trials / Completed

CompletedNCT04868123

Effects of TENS and Mindfulness Meditation in Persons With HIV-related Neuropathy

Pilot Study of Mindfulness Meditation and Transcutaneous Nerve Stimulation (TENS) in Persons Living With HIV-related Peripheral Neuropathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Rutgers University · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

This study is to explore the effects of transcutaneous nerve stimulation (TENS) and mindfulness meditation in persons living with HIV (PLHIV) and painful neuropathy in the feet.

Detailed description

The overall goal of this study is to conduct an interventional pilot trial of mindfulness meditation and transcutaneous nerve stimulation (TENS) to mitigate the symptoms and improved function in persons living with HIV (PLHIV) and painful neuropathy in the feet. . The investigators aim to determine the feasibility and effects of (1) mindfulness meditation or (2) transcutaneous nerve stimulation (TENS) on clinical and functional outcomes in participants with HIV-associated painful distal sensory polyneuropathy in the feet. This aim will be achieved with a randomized control pilot trial with 3 groups: TENS group, Mindfulness Mediation Group, and Usual Treatment (Control) group. The interventions will be performed at home over a period of 6 weeks.

Conditions

Interventions

TypeNameDescription
DEVICETranscutaneous Nerve Stimulation (TENS)Transcutaneous nerve stimulation (TENS) is a simple home base treatment to manage pain. It involves electrical current applied to the skin through self-adhering electrodes, using a TENS3000 device (TENSPros.com).
BEHAVIORALMindfulness MeditationMindfulness mediation is a guided mediation process to improve awareness of being present in the moment.

Timeline

Start date
2022-04-22
Primary completion
2025-01-07
Completion
2025-01-07
First posted
2021-04-30
Last updated
2025-03-07

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04868123. Inclusion in this directory is not an endorsement.